Daniel R. Chard - 28 Sep 2026 Form 4 Insider Report for MEDIFAST INC (MED)

Reporting relationship: Director
Issuer ticker: MED
Reported as of: 28 Sep 2026
Net transaction value: -$226,289
SEC form: 4
Accepted by SEC: 30 Sep 2026, 20:04:53 UTC
Prior SEC filing: 27 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ James P. Maloney, attorney-in-fact

Filing notes and source

Key filing fact

Daniel R. Chard filed Form 4 for MEDIFAST INC (MED) on 30 Sep 2026.

Key facts

This page summarizes Daniel R. Chard's Form 4 filing for MEDIFAST INC (MED).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 30 Sep 2026, 20:04.

Change

Previous filing in this sequence was filed on 27 Mar 2026.
Current net transaction value: -$226,289.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001289557 Primary reporting owner

Chard Daniel R

Relationship: Director
Address: C/O MEDIFAST, INC., 1501 S. CLINTON STREET, SUITE 500, BALTIMORE
Signature: /s/ James P. Maloney, attorney-in-fact
Signature date: 30 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MED transaction

Common Stock

Sale

Transaction value: $114,338
Shares: -9,545
Change %: -6.4%
Price: $11.98
Shares after: 140,153
Date: 28 Sep 2026
Ownership: The Dan and Allyson Family Irrevocable Trust
Footnotes: F1, F2

MED transaction

Common Stock

Sale

Transaction value: $111,951
Shares: -9,544
Change %: -6.8%
Price: $11.73
Shares after: 130,609
Date: 29 Sep 2026
Ownership: The Dan and Allyson Family Irrevocable Trust
Footnotes: F2, F3

MED holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 17,678
Date: 28 Sep 2026
Ownership: Dan and Allyson as Joint Tenants
Footnotes: F4

MED holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 188,233
Date: 28 Sep 2026
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 4 footnotes

Footnote F1

The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $11.900 to $12.125, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F2

These shares are directly owned by The Dan and Allyson Family Irrevocable Trust, for which the reporting person is the Settlor of the Trust and Investment Trustee.

Footnote F3

The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $11.670 to $11.810, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F4

These shares are directly owned by a joint account of which the reporting person owns as a joint tenant with his spouse.